The Effect of Three Different P-glycoprotein Inhibitors on the Pharmacokinetic Behaviors of Paclitaxel

CAO Yi,WU Ke-chun,YANG Zhao-gang,SUN Jia-bei,ZHANG Xuan,ZHANG Qiang
DOI: https://doi.org/10.3321/j.issn:1001-5213.2007.07.009
2007-01-01
Abstract:OBJECTIVE To compare and analysis the effect of three different P-glycoprotein(P-gp)inhibitors on the pharmacokinetic behaviors of paclitaxel by intravenous administration to rats.METHODS 24 Rats were divided into 4 groups.One group was given Taxol alone and the other three groups were given Taxol with Cyclosporin A(CsA),verapamil or quercetin,respectively.Plasma concentration of paclitaxel was analyzed by HPLC,and pharmacokinetics parameters were calculated by 3P97.RESULTS CsA,verapamil and quercetin decreased the elimination of paclitaxel and increased the AUC of paclitaxel.CONCLUSION Paclitaxel undergoes the elimination effect of P-gp and CYP3A,the agents that simultaneously inhibit P-gp and CYP3A could significantly increase the bioavailability and decrease the elimination of paclitaxel.
What problem does this paper attempt to address?